                               SEQUENCE LISTING

<110> SHAPE THERAPEUTICS INC.
 
<120> METHODS AND COMPOSITIONS RELATING TO ENGINEERED GUIDE SYSTEMS FOR
      ADENOSINE DEAMINASE ACTING ON RNA EDITING

<130> 36856-46343/WO (108WO)

<140> PCT/US2021/034099
<141> 2021-05-25

<150> 63/030,030
<151> 2020-05-26

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 45
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
guggaauagu auaacaauau gcuaaauguu guuauaguau cccac                       45


<210> 2
<211> 15
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
guggaauagu auaac                                                        15


<210> 3
<211> 30
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
aauaugcuaa auguuguuau aguaucccac                                        30


<210> 4
<211> 14
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
guggaauagu auaa                                                         14


<210> 5
<211> 31
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 5
caauaugcua aauguuguua uaguauccca c                                      31


